CompletedPHASE1, PHASE2NCT04372498
Senicapoc and Dehydrated Stomatocytosis
Studying Dehydrated hereditary stomatocytosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Carlo Brugnara, MD, MDBoston Children's Hospital
- Intervention
- Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2021 – 2024
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04372498 on ClinicalTrials.govOther trials for Dehydrated hereditary stomatocytosis
Additional recruiting or active studies for the same condition.